Former logo of the Institute
The
Lunenfeld-Tanenbaum Research Institute
is a
medical
research institute
in
Toronto
,
Ontario
and part of the
Sinai Health System
. It was originally established in 1985 as the
Samuel Lunenfeld Research Institute
, the research arm of
Mount Sinai Hospital
, by an endowment from the Lunenfeld and Kunin families. It was renamed to the current name on June 24, 2013, after a $35 million donation from Larry and Judy Tanenbaum.
It comprises 36 principal investigators, has a budget of C$90 million (2005/6), and has over 200 trainees and approximately 600 staff.
[1]
The institute conducts research into various forms of cancer (
colon
,
breast
,
pancreatic
,
prostate
,
lung
, etc.),
neurological disorders
and
brain illnesses
,
women's
and
infants' health
,
diabetes
,
developmental biology
,
stem cell
biology and
tissue regeneration
,
mouse models of human disease
,
genomic medicine
and
systems biology
. The institute has 100,000 sq ft (9,300 m
2
) of space and is split between the main hospital and the Joseph and Wolf Lebovic Health Complex.
The Lunenfeld-Tanenbaum Research Institute is a world pioneer in the fields of
Systems Biology
,
Diabetes
, and
Infectious Bowel Disease
. Its Systems Biology team consistently ranked Top 5 worldwide. Researchers at the Lunenfeld have the highest per capita funding and citations in Canada.
The founding director was
Louis Siminovitch
(1984?1994), followed by
Alan Bernstein
(1995?2000), Janet Rossant and
Anthony Pawson
(2001?2002),
Anthony Pawson
(2002?2005),
James Woodgett
(2005?2021), and Stephen Lye (2021?).
Funding
[
edit
]
Researchers are supported by the Mount Sinai Hospital Foundation, donors and external funding sources including:
[2]
References
[
edit
]
External links
[
edit
]
43°39′27″N
79°23′22″W
/
43.657367°N 79.389557°W
/
43.657367; -79.389557